My interpretation was that his pricing was referring to SC6, not 5.5. My suspicion on the reluctance to give firm guidance number is due mainly to the unknown qty of product to be sold on the spot market. If we get another few BMX auctions this quarter at $6500/t SC6 this will similarly have a pretty material impact on the avg price for the quarter.
Agree with Kyle, communication has been lacking a bit in comparison to peers (AKE have been particularly good at communicating recently), but I don’t think any share holder who has been here for more than a few days could argue that the PLS management team as a whole has been consistent, clear and honest with all of their communication over the last 5 years.
Pap
Spodumene Prices, page-2333
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.00 |
Change
0.060(2.04%) |
Mkt cap ! $9.045B | |||
| Open | High | Low | Value | Volume |
| $3.01 | $3.04 | $2.96 | $47.65M | 15.85M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 47 | 260668 | $3.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.01 | 415827 | 81 |
View Market Depth
| Last trade - 15.48pm 11/07/2024 (20 minute delay) ? |
| PLS (ASX) Chart |